Global Brachytherapy Devices Market: Demand for Advanced Therapies for Treating Cancer to Aid Growth, says TMR

The presence of a large number of companies has rendered the global brachytherapy devices market highly fragmented. In order to accelerate their pace of gains, these companies are therefore adopting strategies such as mergers, acquisitions, and strategic collaborations. Through this, and other strategies aimed at enabling them to expand their footprint, the companies are vying to establish a stronghold globally, finds Transparency Market Research (TMR) in a new study. Eckert and Zieglar BEBIG, Theragenics, CR Bard, Varian Medical Systems, and Elekta are some of the key vendors in the global brachytherapy devices market.

“Considering the rising incidence of cancer witnessed worldwide, the demand for brachytherapy devices is poised to surge in the coming years,” said a lead TMR analyst. Driven by this and various other factors, the global brachytherapy market is forecast to reach US$383.7 mn by the end of 2022, from US$313 mn in 2017. If these figures hold true, the global brachytherapy devices market will rise at a moderate 4.2% CAGR between 2017 and 2022.

Request to view Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=473

Brachytherapy Localizes Effect of Radiation, which is Fueling its Demand

Brachytherapy devices is a segment within the internal radiation therapy equipment market. In brachytherapy, the radiation source is sealed and placed near or inside the body part that may require radiation. Besides treating tumors, brachytherapy is used in the treatment of break, skin, cervix, and prostate cancer. In this technique, the source of radiation is sealed or enclosed within a protective capsule. Hence ionizing radiations escape to treat the cancerous tissues alone and without affecting body fluids.

As healthcare providers and those ailing realize the benefits of brachytherapy over other radiation therapy equipment, the demand for the former will increase. Brachytherapy devices offer high precision in radiation. This in turn limits the effect of radiation only to the diseased or local parts of the anatomy affected by tumors or cancers. The process therefore protects healthier tissues against radiation. Against this backdrop, it can be said that the advent of brachytherapy has paved the way for a safer radiation therapies even in the presence of high and localized doses of radiation

Because of their nature, brachytherapy devices ensure more durable treatment delivery as it is rare that a patient treated with brachytherapy with have reoccurrence of cancer. In some cases brachytherapy is used in combination with surgery, external radiation therapy, or chemotherapy.

Request to download and view full ToC @ https://www.transparencymarketresearch.com/report-toc/473

In the coming years, the market is expected to gain from biotechnological advancements in image guided procedures and dose delivery. Advent of 3D treatment planning is likely to enable physicians obtain results with better accuracy. This, coupled with the rising medical tourism, will enable the market exhibit positive growth in the coming years. Also, market players see significant prospects in the innovation of electronic brachytherapy devices, which constitute a novel technology. Such innovations are likely to open a plethora of opportunities offering lucrative growth prospects to the global brachytherapy market in the forthcoming years.

Strong Competition from External Radiation Therapies Pose Threat

On the downside, the market is facing strong competition from external radiation therapies. Technological advancements in this field could pose threat to the market, thereby hampering its growth during the course of the forecast period. Handling of radiation sources, which are used in treatment and concerns related to storage and procurement are creating obstacles for the market as well. In addition, brachytherapy is not devoid of side effects, however, to an extent it may depend on the location of the treatment. The chances of side effects such as urinary incontinence, desquamation, and localized bleeding could have a negative impact on the global brachytherapy market.

View Report @ https://www.transparencymarketresearch.com/brachytherapy-devices-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.